About 6,185 results

ALLMedicine™ Acinetobacter Center

Research & Reviews  2,159 results

Biocide resistance in Acinetobacter baumannii: Appraising the Mechanisms.
The Journal of Hospital Infection; Shouri Milani E, Hasani A et. al.

Sep 25th, 2021 - A global upsurge in antibiotic resistant Acinetobacter baumannii requires supervised selection of biocides and disinfectants to avert nosocomial infections by reducing its spread. On the other hand, inadequate and improper biocides have been repor...

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward.
CA: a Cancer Journal for Clinicians; Nanayakkara AK, Boucher HW et. al.

Sep 22nd, 2021 - Infection is the second leading cause of death in patients with cancer. Loss of efficacy in antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing success of cancer therapy. In this review, the authors focu...

The K26 capsular polysaccharide from Acinetobacter baumannii KZ-1098: Structure and cle...
International Journal of Biological Macromolecules; Kasimova AA, Arbatsky NP et. al.

Sep 20th, 2021 - The KL26 gene cluster responsible for the synthesis of the K26 capsular polysaccharide (CPS) of Acinetobacter baumannii includes rmlBDAC genes for l-rhamnose (l-Rhap) synthesis, tle to generate 6-deoxy-l-talose (l-6dTalp) from l-Rhap, and a manC g...

Mechanical ventilation-associated pneumonia caused by Acinetobacter baumannii in Northe...
Antimicrobial Resistance and Infection Control; Zhang T, Xu X et. al.

Sep 17th, 2021 - To investigate the clinical features and outcomes of patients with mechanical ventilation-associated pneumonia (VAP) caused by Acinetobacter baumannii (Ab), and to characterize the drug resistance of pathogenic strains and carbapenem resistance-as...

Isolation of extensively drug resistant Acinetobacter baumannii from environmental surf...
American Journal of Infection Control; Ababneh Q, Abulaila S et. al.

Sep 15th, 2021 - Acinetobacter baumannii is a nosocomial pathogen that has emerged as a major threat in the health-care settings, particularly intensive care units (ICUs). The aim of this study was to investigate the prevalence of A. baumannii in the environment o...

see more →

Guidelines  3 results

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the...
Antimicrobial Agents and Chemotherapy; Pogue JM, Jones RN et. al.

Nov 27th, 2019 - The polymyxins are important agents for carbapenem-resistant Gram-negative bacilli. The United States Committee on Antimicrobial Susceptibility Testing breakpoint recommendations for colistin and polymyxin B are that isolates of Pseudomonas aerugi...

Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
Intensive Care Medicine; Garnacho-Montero J, Dimopoulos G et. al.

Oct 7th, 2015 - Acinetobacter baumannii constitutes a dreadful problem in many ICUs worldwide. The very limited therapeutic options available for these organisms are a matter of great concern. No specific guidelines exist addressing the prevention and management ...

Preventing catheter-associated urinary tract infections: An executive summary of the As...
American Journal of Infection Control; Rebmann T, Greene LR

Sep 28th, 2010 - The Association for Professionals in Infection Control and Epidemiology (APIC) began publishing their series of Elimination Guides in 2007. Since then, 9 Elimination Guides have been developed that cover a range of important infection prevention i...

see more →

Drugs  244 results see all →

News  68 results

CDC Doc Addresses Today's Pandemic and the Next

Nov 23rd, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. On July 1, 2020, when I began a rotation on the infectious disease consult service at the Veterans Administration Hospital in Atlanta, we had three patients with...

Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a Result o...

Summary Company Announcement Date: May 28, 2019 FDA Publish Date: May 28, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Sterility Failure Company Name: Heritage Pharmaceuticals Inc. Brand Name: Brand Name(s) Heritage ...

New pediatric therapies show promise for influenza, multidrug-resistant pathogens
Jeff Craven

Nov 14th, 2018 - ORLANDO – More therapies are becoming available for children for the treatment of influenza and multidrug-resistant infections such as Enterobacteriaceae and Acinetobacter, John S. Bradley, MD, said at the annual meeting of the American Academy of.

Top 5 New Antibiotics Advance to Fight Resistant Infections

Oct 8th, 2018 - SAN FRANCISCO — Five standout antibiotics were featured during a pipeline session here at IDWeek 2018. The application process was open to all companies and the agents selected had the most novel data and are likely to have to most impact, said Ce...

Original Study: Should Nitrofurantoin Be Used to Treat Alkaline Urinary Tract Infection?

Jul 11th, 2018 - Results Data were categorized into 16 different bacterial genera or species. Acinetobacter (n = 1), Kluyvera ascorbata (n = 2), and Stenotrophomonas maltophilia (n = 3) were underrepresented in the dataset and therefore were not included in the da.

see more →